Roivant Sciences Ltd. (ROIV) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2026 | $8.21M | +78.5% |
| 2025 | $4.60M | +232.8% |
| 2024 | $1.38M | -89.1% |
| 2023 | $12.69M | -27.2% |
| 2022 | $17.44M | +200.3% |
| 2021 | $5.81M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2026 | $8.21M | +78.5% |
| 2025 | $4.60M | +232.8% |
| 2024 | $1.38M | -89.1% |
| 2023 | $12.69M | -27.2% |
| 2022 | $17.44M | +200.3% |
| 2021 | $5.81M | — |